|
122 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
12 Trials |
|
2436 News |
|
| «12...678910111213141516...4950» |
- Trial completion, Enrollment change: Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions (clinicaltrials.gov) - Nov 15, 2015
P=N/A, N=192, Completed, Sponsor: Valme University Hospital
Recruiting --> Completed | N=500 --> 192
- Enrollment closed: Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM) (clinicaltrials.gov) - Nov 11, 2015
P=N/A, N=960, Active, not recruiting, Sponsor: Medical College of Wisconsin
Recruiting --> Completed | N=500 --> 192 Recruiting --> Active, not recruiting
- Trial completion: HIVBLD: Human Immune Responses Toward HIV-1 Envelope Antigens (clinicaltrials.gov) - Nov 9, 2015
P=N/A, N=8, Completed, Sponsor: St. Jude Children's Research Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV (clinicaltrials.gov) - Oct 29, 2015
P=N/A, N=30, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Recruiting --> Completed | N=100 --> 30 | Trial primary completion date: Jul 2016 --> Mar 2015
- Trial primary completion date: OCTIHIV: Revealing Increased Axonal Loss in Treated HIV Patients (clinicaltrials.gov) - Oct 29, 2015
P=N/A, N=150, Recruiting, Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Recruiting --> Completed | N=100 --> 30 | Trial primary completion date: Jul 2016 --> Mar 2015 Trial primary completion date: Aug 2015 --> Jan 2016
- | trimethoprim/sulfamethoxazole / Generic mfg.
Enrollment closed: Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2) (clinicaltrials.gov) - Oct 28, 2015
P3, N=200, Active, not recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Aug 2015 --> Jan 2016 Recruiting --> Active, not recruiting
- Enrollment closed, Trial primary completion date: Eliciting Affect in Teens in a Virtual World (Project AVATAR) (clinicaltrials.gov) - Oct 27, 2015
P1/2, N=100, Active, not recruiting, Sponsor: Rhode Island Hospital
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Jan 2016
- ||||| Trial initiation date: PRINCE1: PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV) (clinicaltrials.gov) - Oct 26, 2015
P3, N=82, Active, not recruiting, Sponsor: Bristol-Myers Squibb
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Jan 2016 Initiation date: Oct 2010 --> Nov 2011
- | Trial completion, Adherence: A Commitment Device for Medication Adherence Among HIV Patients (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=39, Completed, Sponsor: National Bureau of Economic Research, Inc.
Initiation date: Oct 2010 --> Nov 2011 Active, not recruiting --> Completed
- Trial primary completion date: Test of an Intervention to Improve HIV Care (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=434, Active, not recruiting, Sponsor: Baylor College of Medicine
Active, not recruiting --> Completed Trial primary completion date: Mar 2015 --> Mar 2016
- Trial primary completion date: MAINTAIN: Micronutrients and Antioxidants in HIV Infection (clinicaltrials.gov) - Oct 22, 2015
P2/3, N=218, Active, not recruiting, Sponsor: Ottawa Hospital Research Institute
Trial primary completion date: Mar 2015 --> Mar 2016 Trial primary completion date: Jun 2015 --> May 2014
- ||| Trial completion, Enrollment change: Project PLUS: Positive Lifestyles Using Safety (clinicaltrials.gov) - Oct 21, 2015
P=N/A, N=90, Completed, Sponsor: Yale University
Trial primary completion date: Jun 2015 --> May 2014 Active, not recruiting --> Completed | N=120 --> 90
- Trial completion, Trial primary completion date: OPG-2: Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis (clinicaltrials.gov) - Oct 19, 2015
P=N/A, N=120, Completed, Sponsor: Emory University
Active, not recruiting --> Completed | N=120 --> 90 Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> May 2013
- Trial completion, Adherence: ADHEPTA Study: Adherence Questionnaire in Hepatitis C (clinicaltrials.gov) - Oct 16, 2015
P=N/A, N=1120, Completed, Sponsor: Fundacion IMIM
Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> May 2013 Recruiting --> Completed
- Trial completion, Phase classification, Enrollment change: Emotional Disclosure in HIV (clinicaltrials.gov) - Oct 15, 2015
P=N/A, N=283, Completed, Sponsor: University of Miami
Recruiting --> Completed Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=200 --> 283
- ||| Isentress (raltegravir) / Merck (MSD)
Enrollment closed: RANIA: Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284) (clinicaltrials.gov) - Oct 8, 2015
P2, N=100, Active, not recruiting, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=200 --> 283 Recruiting --> Active, not recruiting
- || HSV vaccine (GEN-003) / Genocea, Shionogi
Trial primary completion date: Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine (clinicaltrials.gov) - Oct 7, 2015
P2, N=315, Active, not recruiting, Sponsor: Genocea Biosciences, Inc.
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2015 --> Mar 2016
- Trial completion: Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia (clinicaltrials.gov) - Oct 7, 2015
P=N/A, N=1000, Completed, Sponsor: Sihanouk Hospital Center of HOPE
Trial primary completion date: Jun 2015 --> Mar 2016 Not yet recruiting --> Completed
- || lopinavir/ritonavir / Generic mfg.
Enrollment closed, Adherence: Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program (clinicaltrials.gov) - Oct 6, 2015
P=N/A, N=165, Active, not recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
Not yet recruiting --> Completed Recruiting --> Active, not recruiting
- ||| Trial completion: Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials (clinicaltrials.gov) - Oct 5, 2015
P=N/A, N=82, Completed, Sponsor: AIDS Malignancy Consortium
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | leucovorin calcium / Generic mfg., cytarabine / Generic mfg.
Trial completion: Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Oct 5, 2015
P2, N=35, Completed, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed Not yet recruiting --> Completed
- Enrollment closed: ANRS CO16: Cohort of HIV Associated Lymphomas (clinicaltrials.gov) - Sep 30, 2015
P=N/A, N=400, Active, not recruiting, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Not yet recruiting --> Completed Recruiting --> Active, not recruiting
- erlotinib / Generic mfg.
Trial termination, Trial primary completion date, Surgery, Metastases: Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection (clinicaltrials.gov) - Sep 29, 2015
P1, N=48, Terminated, Sponsor: National Cancer Institute (NCI)
Recruiting --> Active, not recruiting Recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Sep 2015; No Accrual
- Tivicay (dolutegravir) / ViiV Healthcare, Isentress (raltegravir) / Merck (MSD)
Trial primary completion date, IO biomarker: Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults (clinicaltrials.gov) - Sep 24, 2015
P4, N=20, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Sep 2015; No Accrual Trial primary completion date: Aug 2015 --> Nov 2015
- Trial primary completion date, Adherence: Medication Adherence in Human Immunodeficiency Virus (HIV) (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=32, Recruiting, Sponsor: St. Jude Children's Research Hospital
Trial primary completion date: Aug 2015 --> Nov 2015 Trial primary completion date: Jan 2016 --> Jun 2016
- Trial primary completion date: Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study (clinicaltrials.gov) - Sep 24, 2015
P3, N=72, Active, not recruiting, Sponsor: Institute of Tropical Medicine, Belgium
Trial primary completion date: Jan 2016 --> Jun 2016 Trial primary completion date: Aug 2015 --> Dec 2015
- Edurant (rilpivirine) / J&J, Rekambys (rilpivirine LA) / J&J
Enrollment closed: Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis (clinicaltrials.gov) - Sep 24, 2015
P2, N=132, Active, not recruiting, Sponsor: PATH
Trial primary completion date: Aug 2015 --> Dec 2015 Recruiting --> Active, not recruiting
- | valacyclovir / Generic mfg.
Enrollment closed, Trial primary completion date: Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? (clinicaltrials.gov) - Sep 24, 2015
P3, N=202, Active, not recruiting, Sponsor: University Health Network, Toronto
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Sep 2016
- ||| abacavir / Generic mfg.
Trial completion, Trial primary completion date: ZIAGEN (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=671, Completed, Sponsor: ViiV Healthcare
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Sep 2016 Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Feb 2015
- | Trial completion, Enrollment change, Trial primary completion date: Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age (clinicaltrials.gov) - Sep 24, 2015
P2/3, N=161, Completed, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Feb 2015 Active, not recruiting --> Completed | N=230 --> 161 | Trial primary completion date: Jun 2014 --> Apr 2015
- | Trial completion: Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study (clinicaltrials.gov) - Sep 22, 2015
P1, N=12, Completed, Sponsor: Ottawa Hospital Research Institute
Active, not recruiting --> Completed | N=230 --> 161 | Trial primary completion date: Jun 2014 --> Apr 2015 Active, not recruiting --> Completed
- Trial completion, Enrollment change: RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice (clinicaltrials.gov) - Sep 21, 2015
P=N/A, N=2044, Completed, Sponsor: Holdsworth House Medical Practice
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=1000 --> 2044
- ||||| Triumeq (dolutegravir/abacavir/lamivudine) / ViiV Healthcare
Enrollment change: A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen (clinicaltrials.gov) - Sep 21, 2015
P3, N=554, Active, not recruiting, Sponsor: ViiV Healthcare
Active, not recruiting --> Completed | N=1000 --> 2044 N=428 --> 554
- | amphotericin b liposome / Generic mfg.
Enrollment closed, Combination therapy, Monotherapy: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (clinicaltrials.gov) - Sep 18, 2015
P3, N=132, Active, not recruiting, Sponsor: Drugs for Neglected Diseases
N=428 --> 554 Recruiting --> Active, not recruiting
- | emtricitabine/tenofovir disoproxil fumarate / Generic mfg.
Enrollment closed: PREP-5: PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5 (clinicaltrials.gov) - Sep 17, 2015
P4, N=50, Active, not recruiting, Sponsor: St. Michael's Hospital, Toronto
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||| Trial completion, Trial primary completion date: Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing (clinicaltrials.gov) - Sep 8, 2015
P=N/A, N=1600, Completed, Sponsor: G & W Laboratories Inc.
Recruiting --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: Dec 2011 --> Dec 2012
- |||| lopinavir/ritonavir / Generic mfg.
Trial completion, Trial primary completion date: Induction-maintenance of Lopinavir/r in HIV-infected Subjects (clinicaltrials.gov) - Sep 8, 2015
P4, N=100, Completed, Sponsor: The Huesped Foundation
Recruiting --> Completed | Trial primary completion date: Dec 2011 --> Dec 2012 Active, not recruiting --> Completed | Trial primary completion date: Dec 2008 --> Dec 2009
- || Enrollment closed: Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials (clinicaltrials.gov) - Sep 3, 2015
P=N/A, N=100, Active, not recruiting, Sponsor: AIDS Malignancy Consortium
Active, not recruiting --> Completed | Trial primary completion date: Dec 2008 --> Dec 2009 Recruiting --> Active, not recruiting
- fludarabine IV / Generic mfg., mycophenolate mofetil / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date, Combination therapy, IO biomarker, Post-transplantation: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (clinicaltrials.gov) - Sep 1, 2015
P=N/A, N=5, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Recruiting --> Active, not recruiting Recruiting --> Completed | N=20 --> 5 | Trial primary completion date: Dec 2015 --> Nov 2014
- Juluca (dolutegravir/rilpivirine) / ViiV Healthcare, J&J
Enrollment change, Trial withdrawal, Head-to-Head: Dolutegravir + Rilpivirine Switch Study (DORISS) (clinicaltrials.gov) - Aug 28, 2015
P2/3, N=0, Withdrawn, Sponsor: Nantes University Hospital
Recruiting --> Completed | N=20 --> 5 | Trial primary completion date: Dec 2015 --> Nov 2014 N=300 --> 0 | Not yet recruiting --> Withdrawn
- Trial completion: Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers (clinicaltrials.gov) - Aug 26, 2015
P1, N=65, Completed, Sponsor: International AIDS Vaccine Initiative
N=300 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- |||| Tivicay (dolutegravir) / ViiV Healthcare
Trial completion: A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir (clinicaltrials.gov) - Aug 26, 2015
P2, N=51, Completed, Sponsor: ViiV Healthcare
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: TBTech: Clinical Decision-support Reminders to Improve IPT Initiation Among HIV Positive Adults in Western Kenya (clinicaltrials.gov) - Aug 25, 2015
P=N/A, N=1000, Completed, Sponsor: Indiana University
Active, not recruiting --> Completed Not yet recruiting --> Completed | Trial primary completion date: Dec 2014 --> Aug 2014
- |||| GSK692342 / GSK, Bill & Melinda Gates Foundation
Trial completion, IO biomarker: Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults (clinicaltrials.gov) - Aug 24, 2015
P2, N=240, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Completed | Trial primary completion date: Dec 2014 --> Aug 2014 Active, not recruiting --> Completed
- Trial primary completion date: MICROBREAK1: Prevalence of Cerebral Small Vessel Disease in HIV Infected Patients (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=750, Recruiting, Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> Jun 2016
- Trial primary completion date: MICROGUT: Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients (clinicaltrials.gov) - Aug 21, 2015
P=N/A, N=100, Recruiting, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Trial primary completion date: Jun 2015 --> Jun 2016 Trial primary completion date: May 2015 --> Dec 2015
- Phase classification: Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya (clinicaltrials.gov) - Aug 20, 2015
P=N/A, N=140, Terminated, Sponsor: University of Washington
Trial primary completion date: May 2015 --> Dec 2015 Phase classification: P3 --> P=N/A
- Enrollment closed, Trial primary completion date, HEOR, Cost effectiveness: Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=100, Active, not recruiting, Sponsor: George Washington University
Phase classification: P3 --> P=N/A Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016
- |||| rosuvastatin / Generic mfg.
Trial completion, Trial primary completion date: Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks (clinicaltrials.gov) - Aug 17, 2015
P2, N=144, Completed, Sponsor: University Hospital Case Medical Center
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016 Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2014
- methamphetamine / Generic mfg.
Trial primary completion date: Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=450, Recruiting, Sponsor: University of Colorado, Denver
Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2014 Trial primary completion date: Jun 2015 --> Oct 2015